US20100198337A1 - Helical Formation for a Conduit - Google Patents

Helical Formation for a Conduit Download PDF

Info

Publication number
US20100198337A1
US20100198337A1 US12/756,780 US75678010A US2010198337A1 US 20100198337 A1 US20100198337 A1 US 20100198337A1 US 75678010 A US75678010 A US 75678010A US 2010198337 A1 US2010198337 A1 US 2010198337A1
Authority
US
United States
Prior art keywords
conduit
helical formation
helical
helix angle
flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/756,780
Inventor
John Graeme Houston
Robert Gordon Hood
Peter Arno Stonebridge
Allan Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tayside Flow Technologies Ltd
Original Assignee
Tayside Flow Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2002/002580 external-priority patent/WO2002098325A2/en
Application filed by Tayside Flow Technologies Ltd filed Critical Tayside Flow Technologies Ltd
Priority to US12/756,780 priority Critical patent/US20100198337A1/en
Publication of US20100198337A1 publication Critical patent/US20100198337A1/en
Assigned to TAYSIDE FLOW TECHNOLOGIES LIMITED reassignment TAYSIDE FLOW TECHNOLOGIES LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THOMSON, ALLAN, HOUSTON, JOHN GRAEME, STONEBRIDGE, PETER ARNO, HOOD, ROBERT GORDON
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F15FLUID-PRESSURE ACTUATORS; HYDRAULICS OR PNEUMATICS IN GENERAL
    • F15DFLUID DYNAMICS, i.e. METHODS OR MEANS FOR INFLUENCING THE FLOW OF GASES OR LIQUIDS
    • F15D1/00Influencing flow of fluids
    • F15D1/02Influencing flow of fluids in pipes or conduits
    • F15D1/06Influencing flow of fluids in pipes or conduits by influencing the boundary layer
    • F15D1/065Whereby an element is dispersed in a pipe over the whole length or whereby several elements are regularly distributed in a pipe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/068Modifying the blood flow model, e.g. by diffuser or deflector

Abstract

A helical formation within a conduit and a method of determining the helix angle of the helical formation are disclosed. The method includes specifying the internal dimensions of the conduit and an intended fluid mass flow through the conduit. The helix angle is determined from the pressure drop and the turbulent kinetic energy for a conduit having the specified internal dimensions and intended fluid mass flow.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims priority of U.S. patent application Ser. No. 10/516,875, with a U.S. filing date of Dec. 3, 2004. U.S. application Ser. No. 10/516,875 is a 371 filing of PCT/GB02/05646, filed on Dec. 13, 2002 which in turn claims priority of PCT/GB02/02580, filed on Jun. 5, 2002.
  • Furthermore, the underlying concepts, but not necessarily the language, of U.S. patent application Ser. No. 10/516,875 are incorporated herein by reference.
    • If there are any contradictions or inconsistencies in language between this application and the case that have been incorporated by reference that might affect the interpretation of the claims in this case, the claims in this case should be interpreted to be consistent with the language in this case.
    FIELD OF INVENTION
  • The invention relates to a method of determining the helix angle of a helical formation for a conduit, and in particular, but not solely, for blood flow tubing.
  • BACKGROUND OF THE INVENTION
  • A number of documents have proposed using helical formations in conduits to encourage a desired flow pattern of a fluid within the conduit. Such helical formations have been proposed for a wide variety of applications, including pipelines and blood flow tubing. The purpose of the helical formations is generally to generate spiral flow of the fluid within the conduit to reduce turbulence and dead spots within the conduit.
  • Although the use of helical formations has been proposed as beneficial to fluid flow in conduits by helping to generate spiral fluid flow patterns, there is little or no information on the physical characteristics or design of the helical formation that is required to create a suitable spiral flow pattern. Clearly, some designs of helical formations will be ineffective at creating spiral flow and others will not create a beneficial spiral flow. For example, helical formations having a high helix angle may tend to create turbulence rather than spiral flow due.
  • SUMMARY OF THE INVENTION
  • In accordance with a first aspect of the present invention, there is provided a helical formation for a conduit, the helical formation defining at least a portion of a helix, the angle of the helix defined by the helical formation being determined from the internal dimensions of the conduit, the fluid mass flow of the conduit, the pressure drop along the conduit and the turbulent kinetic energy within the conduit.
  • In accordance with a second aspect of the present invention, there is provided a method of determining the helix angle of a helical formation for a conduit, the method comprising specifying the internal dimensions of the conduit and an intended fluid mass flow through the conduit, and determining the helix angle from the pressure drop and the turbulent kinetic energy for a conduit having the specified internal dimensions and intended fluid mass flow.
  • The terms “helical”, “helix” and “spiral” as used herein cover the mathematical definition of helical and any combination of the mathematical definitions of helical and spiral.
  • Typically, the pressure drop and the turbulent kinetic energy are non-dimensionalised before the helix angle is determined.
  • Preferably, the helix angle is determined as the helix angle at which the non-dimensionalised pressure drop and the non-dimensionalised turbulent kinetic energy are substantially equal. However, the helix angle could be determined as a helix angle at which the non-dimensionalised pressure drop and the non-dimensionalised turbulent kinetic energy are not equal, depending on the type of conduit, the fluid and/or the application.
  • The helical formation may have a helix angle of between 5° and 50°. For example, the helical formation may have a helix angle of about 8°, particularly but not exclusively in relation to arterial flow in leg arterial grafts.
  • Typically, the fluid to be carried by the conduit comprises a liquid. The fluid may be solely a liquid, a liquid mixed with a particulate solid, or a liquified solid. For example, where the conduit is a blood vessel, the liquid is blood.
  • Typically, the helical formation may effect a rotational flow of fluid within the conduit, in use. The rotational flow may comprise a helical and/or spiral flow component.
  • Preferably, the helical formation may comprise an elongate member. Typically, the elongate member comprises an inwardly extending portion.
  • In one example of the invention, the helical formation may be in the form of an insert adapted to be mounted permanently or temporarily within the conduit.
  • In another example of the invention, the helical formation may be an integral part of the conduit and may be formed, for example, by a deformation of a side wall of the conduit.
  • The helical formation may effect helical and/or spiral flow in such a fashion as to eliminate or reduce turbulence and/or eliminate or reduce dead flow regions in the conduit. The helix angle to achieve such flow will depend on such factors as diameter of the conduit, longitudinal and rotational velocity of the fluid, and the viscosity and other characteristics of the fluid.
  • The conduit may comprise tubing. For example, the conduit may comprise artificial or natural blood flow tubing, such as a vascular graft or a blood vessel, respectively. The tubing may be used in blood treatment or delivery equipment, for example a heart-lung machine, dialysis equipment or a giving set. The tubing may also be used in industrial equipment, for example hoses, pipes or fire hoses.
  • Alternatively, the conduit may comprise a stent. Stents, for example made of mesh, expanded sheet or tube or wire spring type, are inserted into blood vessels to provide mechanical support and prevent collapse of the blood vessel. A structure according to the present invention could be placed inside or outside the blood vessel to impose, maintain and/or reinforce a flow guiding formation through the blood vessel.
  • The invention may also be utilised for stent grafts. That is, a combination of stent and graft.
  • Flow configuration through a conduit may, in general, be measured using such techniques as magnetic resonance imaging (MRI) and/or Doppler ultrasound, and the flow guiding formation may be modified accordingly until a desired flow configuration is achieved. Initial design of flow configuration may be by mathematical modelling or by trial and error, with modification as described above.
  • The conduit may be a flexible conduit, such as a tube or hose, or a substantially rigid conduit, such as a metal pipe or a pipeline.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • Examples of a method of determining the helix angle of a helical formation will now be described with reference to the accompanying drawings, in which:
  • FIG. 1 is a perspective view of an arterial graft having a helical formation; and
  • FIG. 2 is a graph of helix angle versus pressure drop and helix angle versus turbulent kinetic energy for the arterial graft.
  • DETAILED DESCRIPTION
  • FIG. 1 is a perspective view of an arterial graft 1 for implantation in the human or animal body. The graft 1 is fabricated from a knitted or woven polyester material. However, any suitable flexible material could be used, such as a spun polyurethane multi-monofilament or a PTFE extrusion.
  • The graft 1 is in the form of a tube 2 that has a deformation 3 in the side wall of the tube 2 so that the deformation 3 extends inwardly generally towards the longitudinal axis of the tube 2 to form a helical formation 4 on the internal surface of the tube 2. The tube is also crimped to form circumferential ridges 5 along the length of the tube 2. The circumferential ridges help to provide radial strength to the tube 2 to minimise the risk of the graft collapsing during implantation and subsequently during use.
  • The helical formation 4 is intended to promote a rotational flow pattern to blood passing through the graft 1, in use. It is believed that rotational flow has beneficial effects in reducing the effect of and helping to prevent arterial diseases, by reducing turbulent flow and reducing dead spots within the flow.
  • The inventors have found that the choice of the helix angle of the helical formation 4 is important in minimising turbulent flow and dead spots within the flow. The inventors have also found that for a conduit having given internal dimensions and a particular helical flow formation that is intended to carry a given mass flow, the optimum helix angle can be determined from the pressure drop along the conduit and the turbulent kinetic energy in the conduit.
  • In addition, the inventors have found that, in order to maintain a given mass flow in a given conduit, with a particular helical flow formation, the pressure drop increases as the helix angle increases and the turbulent kinetic energy decreases as the helix angle increases. Hence, the choice of helix angle is a compromise between minimising pressure drop and minimising turbulent kinetic energy. If the pressure drop and turbulent kinetic energy are non-dimensionalised using conventional mathematical techniques, the curves of helix angle versus non-dimensionalised pressure drop and helix angle versus turbulent kinetic energy can be plotted on the same graph. A curve 50 of helix angle versus non-dimensionalised pressure drop and a curve 51 of helix angle versus non-dimensionalised turbulent kinetic energy for an arterial graft are shown in FIG. 2. These curves 50, 51 were obtained from measuring pressure drop and turbulent kinetic energy in the arterial graft 1 using conventional techniques. The curves 50, 51 show that at the region 52, the curves intersect and this intersection occurs at a helix angle of approximately 8°.
  • By also analysing flow in the graft 1 using conventional magnetic resonance imaging techniques it was found by trial and error that the optimum helix angle for the graft 1 for the given mass flow was also approximately 8°. Hence, the optimum helix angle for the graft 1 occurs at approximately when the non-dimensionalised pressure drop is approximately equal to the non-dimensionalised turbulent kinetic energy.
  • Although in the example described above the helix angle is determined as the angle at which the non-dimensionalised pressure drop and turbulent kinetic energy are substantially equal, there may be situations in which the helix angle is selected so that the non-dimensionalised pressure drop and turbulent kinetic energy are not equal. This may situation may arise if, for example, a lower turbulent kinetic energy is required and it is decided to tolerate a higher pressure drop to obtain a lower turbulent kinetic energy. Similarly, if a low pressure drop is more important than turbulent kinetic energy, a higher turbulent kinetic energy may be tolerated to obtain a lower pressure drop. Hence, the choice of the helix angle can be chosen according to the particular application, and different applications may have different requirements.
  • In the example described above, the helix angle of the helical formation is determined for the graft 1. However, the same technique can be used for other conduits where it is desired to use a helical formation to alter the flow pattern of fluid the conduit. For example, the same technique could also be used to determine the helix angle for a helical formation for use in a stent, or indeed any other medical application involving the flow of a fluid through a tube.
  • The present invention is also suitable for industrial applications. Helical formations may also be used in conduits such as tubes to create improved efficiency through quicker transfer of fluid and reduced energy use or a reduction in pressure gradient along the tube allowing lower pressures within the tube to deliver a specific end conduit pressure/flow rate. Helical formations could be used to effect a reduction in turbulence, thereby reducing vibration, noise, and/or fatigue in a conduit, which in pumps could allow for reduced pump power consumption. Helical formations may also be used to allow further penetration or more accurate distribution patterns of fluid exiting a conduit, for example from a hose pipe for domestic use or from a fire hose. The invention will also be of benefit to industries where slurries or suspensions are transported through conduits, for example food producers or distributors involved with soups, sauces and like products.
  • As with the example above of the graft 1, the optimum helix angle for these other types of conduits can be determined from the pressure drop and the turbulent kinetic energy.
  • Therefore, the invention has the advantage of enabling the helix angle of a helical flow formation in a given size of conduit intended to carry a given fluid to be determined from the pressure drop and the turbulent kinetic energy in the conduit.

Claims (13)

1. A helical formation for a conduit, the helical formation defining at least a portion of a helix, the helical formation being made by a process comprising the steps of:
(i) determining an angle of the helix defined by the helical formation from the internal dimensions of the conduit, the fluid mass flow of the conduit, the pressure drop along the conduit and the turbulent kinetic energy within the conduit; and
(ii) producing the helical formation with the helix angle as determined in step (i).
2. A helical formation according to claim 1, wherein the helix angle is between 5° and 50°.
3. A helical formation according to claim 1, wherein the helix angle is between 5° and 20°.
4. A helical formation according to claim 1, wherein the helix angle is substantially 8°.
5. A helical formation according to claim 1, wherein the helical formation is for effecting a rotational flow of fluid within the conduit, in use.
6. A helical formation according to claim 1, wherein the helical formation comprises an elongate member.
7. A helical formation according to claim 6, wherein the elongate member comprises an inwardly extending portion.
8. A helical formation according to claim 1, wherein the helical formation is in the form of an insert adapted to be mounted within the conduit.
9. A helical formation according to claim 1, wherein the helical formation is an integral part of the conduit.
10. A conduit comprising a helical formation according to claim 1.
11. A conduit according to claim 10, wherein the conduit is blood flow tubing.
12. A conduit according to claim 11, wherein the blood flow tubing comprises a graft.
13. A conduit according to claim 11, wherein the blood flow tubing comprises a stent.
US12/756,780 2002-06-05 2010-04-08 Helical Formation for a Conduit Abandoned US20100198337A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/756,780 US20100198337A1 (en) 2002-06-05 2010-04-08 Helical Formation for a Conduit

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBPCT/GB02/02580 2002-06-05
PCT/GB2002/002580 WO2002098325A2 (en) 2001-06-05 2002-06-05 Means for effecting a fluid flow pattern in a conduit
PCT/GB2002/005646 WO2003103540A1 (en) 2002-06-05 2002-12-13 A method of determining the helix angle of a helical formation for a conduit
US10/516,875 US7721767B2 (en) 2002-06-05 2002-12-13 Method of determining the helix angle of a helical formation for a conduit
US12/756,780 US20100198337A1 (en) 2002-06-05 2010-04-08 Helical Formation for a Conduit

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB2002/005646 Continuation WO2003103540A1 (en) 2002-06-05 2002-12-13 A method of determining the helix angle of a helical formation for a conduit
US10/516,875 Continuation US7721767B2 (en) 2002-06-05 2002-12-13 Method of determining the helix angle of a helical formation for a conduit

Publications (1)

Publication Number Publication Date
US20100198337A1 true US20100198337A1 (en) 2010-08-05

Family

ID=29725424

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/516,875 Active 2025-11-04 US7721767B2 (en) 2002-06-05 2002-12-13 Method of determining the helix angle of a helical formation for a conduit
US12/756,780 Abandoned US20100198337A1 (en) 2002-06-05 2010-04-08 Helical Formation for a Conduit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/516,875 Active 2025-11-04 US7721767B2 (en) 2002-06-05 2002-12-13 Method of determining the helix angle of a helical formation for a conduit

Country Status (5)

Country Link
US (2) US7721767B2 (en)
EP (1) EP1509169B1 (en)
JP (1) JP2005528184A (en)
AU (1) AU2002350953A1 (en)
WO (1) WO2003103540A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015534015A (en) * 2012-09-21 2015-11-26 エヌジー1 テクノロジーズ,エルエルシー Pipeline system and method

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR982302A0 (en) * 2002-01-03 2002-01-31 Pax Fluid Systems Inc. A fluid flow controller
GB0227369D0 (en) * 2002-11-23 2002-12-31 Tayside Flow Technologies Ltd A helical formation for a conduit
JP4740118B2 (en) * 2003-03-18 2011-08-03 ヴェリヤン・メディカル・リミテッド Helical stent
GB0306176D0 (en) 2003-03-18 2003-04-23 Imp College Innovations Ltd Tubing
GB0402736D0 (en) * 2004-02-06 2004-03-10 Tayside Flow Technologies Ltd A drug delivery device
GB0423422D0 (en) 2004-10-21 2004-11-24 Bard Inc C R Medical device for fluid flow, and method of forming such device
DE102005019649A1 (en) * 2005-04-26 2006-11-02 Alveolus Inc. Flexible stent for positioning in lumen of esophagus comprises tube and stabilization members defined circumferentially about tube, where each member extends inwardly in tube to define inner diameter that is less than inner diameter of tube
GB2429650A (en) * 2005-09-06 2007-03-07 Tayside Flow Technologies Ltd A tubular graft
US10245165B2 (en) * 2009-04-02 2019-04-02 Q3 Medical Devices Limited Stent
US9597214B2 (en) 2008-10-10 2017-03-21 Kevin Heraty Medical device
US8177498B2 (en) * 2009-04-21 2012-05-15 Ford Global Technologies, Llc Inlet swirl control for turbochargers
US8250891B2 (en) * 2009-05-15 2012-08-28 Ching-Chi Chung Tube
US9611967B2 (en) 2012-01-19 2017-04-04 Joseph Dugan Internally heated fluid transfer pipes with internal helical heating ribs
KR101628711B1 (en) * 2014-06-26 2016-06-09 주식회사 에스앤지바이오텍 Stent With External Flow Path
JP6356556B2 (en) * 2014-09-24 2018-07-11 株式会社吉野工業所 Blow molding equipment
GB201508593D0 (en) * 2015-05-19 2015-07-01 Vascular Flow Technologies Ltd A stent
US10893929B2 (en) 2018-01-10 2021-01-19 Cook Medical Technologies Llc Vascular graft with compartments for compliance matching
US10517713B2 (en) * 2018-01-10 2019-12-31 Cook Medical Technologies Llc Vascular graft with helical flow compliance compartments
EP3542692A1 (en) * 2018-03-22 2019-09-25 HILTI Aktiengesellschaft Vacuum cleaner hose

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313577A (en) * 1965-03-15 1967-04-11 Wolfe Samuel Edmund Method and apparatus for transporting slurries
US4629458A (en) * 1985-02-26 1986-12-16 Cordis Corporation Reinforcing structure for cardiovascular graft
US6514284B1 (en) * 2000-04-20 2003-02-04 Advanced Cardiovascular Systems, Inc. Stent having inner flow channels
US20030225453A1 (en) * 1999-03-03 2003-12-04 Trivascular, Inc. Inflatable intraluminal graft
US6776194B2 (en) * 2001-06-05 2004-08-17 Tayside Flow Technologies Limited Flow means

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB409528A (en) * 1933-06-28 1934-05-03 Aerol Engine Corp Improvements in liquid conducting conduits
GB9828696D0 (en) 1998-12-29 1999-02-17 Houston J G Blood-flow tubing
WO2001089419A1 (en) 2000-05-19 2001-11-29 C.R. Bard, Inc. Stents and stenting methods
DE10056673A1 (en) 2000-11-10 2002-05-29 Deutsch Zentr Luft & Raumfahrt System for conveying of surface inclusion and/or discharge of substance by fluid e.g. in fuel cell, comprises flow duct forming laminar fluid flow and with flow conducting unit effecting spatial rearrangement of fluid layers
GB2373058B (en) * 2001-09-18 2003-02-19 Tayside Flow Technologies Ltd Spiral flow testing
GB2369797B (en) * 2001-11-20 2002-11-06 Tayside Flow Technologies Ltd Helical formations in tubes

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313577A (en) * 1965-03-15 1967-04-11 Wolfe Samuel Edmund Method and apparatus for transporting slurries
US4629458A (en) * 1985-02-26 1986-12-16 Cordis Corporation Reinforcing structure for cardiovascular graft
US20030225453A1 (en) * 1999-03-03 2003-12-04 Trivascular, Inc. Inflatable intraluminal graft
US6514284B1 (en) * 2000-04-20 2003-02-04 Advanced Cardiovascular Systems, Inc. Stent having inner flow channels
US6776194B2 (en) * 2001-06-05 2004-08-17 Tayside Flow Technologies Limited Flow means

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015534015A (en) * 2012-09-21 2015-11-26 エヌジー1 テクノロジーズ,エルエルシー Pipeline system and method

Also Published As

Publication number Publication date
EP1509169B1 (en) 2012-10-10
JP2005528184A (en) 2005-09-22
US20060047334A1 (en) 2006-03-02
AU2002350953A1 (en) 2003-12-22
WO2003103540A1 (en) 2003-12-18
EP1509169A1 (en) 2005-03-02
US7721767B2 (en) 2010-05-25

Similar Documents

Publication Publication Date Title
US20100198337A1 (en) Helical Formation for a Conduit
EP1269935B1 (en) Means for effecting a fluid flow pattern in a conduit
US10188532B2 (en) Blood-flow tubing
US7185677B2 (en) Helical formation for a conduit
US8236043B2 (en) Stent
CN103747761A (en) Branched stent graft device and deployment
CN107205811B (en) From curved stent graft
CN104797213B (en) Apparatus in flexible chamber
CN105050547B (en) Support
US8808354B2 (en) Helical stent
EP1603490B1 (en) Device for placement externally of a body fluid flow conduit
JP2014205068A (en) Medical device suitable for deployment in body lumen
JPS62112567A (en) Composite tube and method for sampaling or injecting of fluid using said tube
US8454675B2 (en) Internal formation for a conduit
AU2006260681A1 (en) Artificial graft tubing
CN106073958B (en) A kind of Medical rack and its manufacturing method
JP2004305450A (en) Evenly expanding flexible stent with excellent blood vessel trackability
WO2005054737A1 (en) Fluid conduit with improved flow
Totorean et al. A helical pipe investigation from a cardiovascular perspective
Ban et al. Development of an insertion-type peristalsis pump

Legal Events

Date Code Title Description
AS Assignment

Owner name: TAYSIDE FLOW TECHNOLOGIES LIMITED, UNITED KINGDOM

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOUSTON, JOHN GRAEME;HOOD, ROBERT GORDON;STONEBRIDGE, PETER ARNO;AND OTHERS;SIGNING DATES FROM 20050210 TO 20050320;REEL/FRAME:025107/0985

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION